相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors
Betsy Hirsch et al.
BLOOD (2011)
Tumor incidence in related hematopoietic stem cell donors
A. Jeger et al.
BONE MARROW TRANSPLANTATION (2011)
The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation
H. K. Al-Ali et al.
BONE MARROW TRANSPLANTATION (2011)
WMDA guidelines for subsequent donations following initial BM or PBSCs
D. L. Confer et al.
BONE MARROW TRANSPLANTATION (2011)
The EBMT activity survey 2009: trends over the past 5 years
H. Baldomero et al.
BONE MARROW TRANSPLANTATION (2011)
Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States
Paul V. O'Donnell et al.
BLOOD (2010)
Family donor care management: principles and recommendations
S. M. van Walraven et al.
BONE MARROW TRANSPLANTATION (2010)
Comparison of general vs regional anaesthesia for BM harvesting: a retrospective study of anaesthesia-related complications
M. Machaczka et al.
BONE MARROW TRANSPLANTATION (2010)
Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations
B. E. Shaw et al.
BONE MARROW TRANSPLANTATION (2010)
Hematopoietic Stem Cell Transplantation A Global Perspective
Alois Gratwohl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures
Robert E. Donahue et al.
BLOOD (2009)
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors
Kristina Hoelig et al.
BLOOD (2009)
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program
Michael A. Pulsipher et al.
BLOOD (2009)
Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study
G. C. Leitner et al.
BONE MARROW TRANSPLANTATION (2009)
Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience
M. Martino et al.
BONE MARROW TRANSPLANTATION (2009)
Severe events in donors after allogeneic hematopoietic stem cell donation
Joerg Halter et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Recovery and safety profiles of marrow and PBSC donors: Experience of the National Marrow Donor Program
John P. Miller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health
N. Sacchi et al.
BONE MARROW TRANSPLANTATION (2008)
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor
Ingmar Bruns et al.
HAEMATOLOGICA (2008)
Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry
Javier de la Rubia et al.
HAEMATOLOGICA (2008)
Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis
Ping Jin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors
Derwood Pamphilon et al.
TRANSFUSION (2008)
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges
Paolo Anderlini et al.
BLOOD (2008)
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Sophia S. Wang et al.
BLOOD (2007)
Long-term safety of filgrastim (rhG-CSF) administration
Dennis L. Confer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals
Ulrike Bacher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
Charles L. Bennett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study
C Tassi et al.
BONE MARROW TRANSPLANTATION (2005)
Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes
JM Hernández et al.
LEUKEMIA (2005)
Long-term persistent lymphopenia in hematopoietic stem cell donors after donation for donor lymphocyte infusion
FE Nicolini et al.
EXPERIMENTAL HEMATOLOGY (2004)
An evaluation of the donor experience in the Canadian multicenter randomized trial of bone marrow versus peripheral blood allografting
C Bredeson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Transmission of donor illness by stem cell transplantation:: should screening be different in older donors?
D Niederwieser et al.
BONE MARROW TRANSPLANTATION (2004)
Differences between graft product and donor side effects following bone marrow or stem cell donation
G Favre et al.
BONE MARROW TRANSPLANTATION (2003)
Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF
C Kaplinsky et al.
BONE MARROW TRANSPLANTATION (2003)
分享论文
